Bastion Asset Management Inc. Takes Position in Progyny, Inc. (NASDAQ:PGNY)

Bastion Asset Management Inc. acquired a new stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 50,044 shares of the company's stock, valued at approximately $850,000. Bastion Asset Management Inc. owned 0.06% of Progyny at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Leibman Financial Services Inc. increased its holdings in shares of Progyny by 100.7% during the 4th quarter. Leibman Financial Services Inc. now owns 63,509 shares of the company's stock worth $1,096,000 after purchasing an additional 31,872 shares during the period. Fort Washington Investment Advisors Inc. OH grew its position in Progyny by 90.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company's stock worth $25,319,000 after buying an additional 695,740 shares in the last quarter. Clear Harbor Asset Management LLC bought a new position in Progyny during the fourth quarter valued at about $989,000. Barclays PLC raised its holdings in Progyny by 530.4% in the 3rd quarter. Barclays PLC now owns 706,157 shares of the company's stock valued at $11,835,000 after acquiring an additional 594,140 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its position in shares of Progyny by 52.2% in the 4th quarter. Baillie Gifford & Co. now owns 1,332,690 shares of the company's stock worth $22,989,000 after acquiring an additional 456,853 shares during the period. Institutional investors and hedge funds own 94.93% of the company's stock.

Progyny Price Performance

Shares of PGNY traded down $2.49 on Friday, hitting $20.88. The company's stock had a trading volume of 2,109,958 shares, compared to its average volume of 1,745,735. The company has a 50 day moving average price of $21.96 and a 200 day moving average price of $19.47. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $32.57. The company has a market capitalization of $1.79 billion, a PE ratio of 36.00, a PEG ratio of 2.39 and a beta of 1.37.

Progyny (NASDAQ:PGNY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). Progyny had a return on equity of 11.36% and a net margin of 5.03%. The business had revenue of $324.04 million during the quarter, compared to analyst estimates of $307.86 million. During the same period in the prior year, the firm posted $0.17 EPS. Progyny's revenue for the quarter was up 16.5% compared to the same quarter last year. On average, equities analysts forecast that Progyny, Inc. will post 0.6 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on PGNY shares. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective on the stock in a research report on Monday, March 31st. JPMorgan Chase & Co. boosted their price target on shares of Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a report on Tuesday, January 28th. Bank of America raised their price objective on shares of Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Finally, Canaccord Genuity Group increased their price target on shares of Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research report on Friday, February 28th. Eight investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $23.64.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.